Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286883 · ClinicalTrials.gov registry record
Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 33
- Enrollment target
NCT01286883 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT01286883 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The study will enroll patients with metastatic colorectal cancer receiving chemotherapy. A total of approximately 22 cc of blood will be drawn during various chemotherapy infusions. Additional proposed laboratory studies may unravel important biological insights into the relationship of circulating tumor cell genomic and genetic profiles as they compare to the primary tumors. Additionally the investigators hope to gain an understanding of potential subgroups of patients that have very high numbers of circulating tumor cells or those with early relapse of circulating tumor cells after early reduction of circulating tumor cell numbers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286883
The ClinicalTrials.gov registry entry for NCT01286883 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01286883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01286883 about?
NCT01286883 is a clinical study titled "Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells". The study will enroll patients with metastatic colorectal cancer receiving chemotherapy. A total of approximately 22 cc of blood will be drawn during various chemotherapy infusions. Additional proposed laboratory studies may unravel important biological insights into the relationship of circulating ...
What is the current status of trial NCT01286883?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2011-02. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01286883?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.